comparemela.com

Latest Breaking News On - Lucie larguier - Page 7 : comparemela.com

Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France
United-states
Paris
France-general
New-york
Transgene-euronext
Lucie-larguier
Twitter
Corporate-communications
Investor-access-forum
Global-healthcare-conference
Access-forum

Transgene Receives $15.3 Million from the Sale of Securities Held for Sale

Transgene Receives $15.3 Million from the Sale of Securities Held for Sale
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China
Chinese
Transgene-euronext
Sylvie-berrebi
Lucie-larguier
Corporate-communications
Twitter
Regulatory-news
Euronext-paris
Artificial-intelligence
Risk-factors
Universal-registration-document

Transgene Receives $15.3 Million from the Sale of Securities Held for Sale

Transgene Receives $15.3 Million from the Sale of Securities Held for Sale
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

China
Chinese
Lucie-larguier
Transgene-euronext
Corporate-communications
Twitter
Linkedin
Regulatory-news
Euronext-paris
Artificial-intelligence
Risk-factors
Universal-registration-document

Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023

New immunological data assessed by tetramer staining confirms the induction of T cell responses in treated patients All trial patients treated with TG4050 monotherapy continue to remain in remission

France
Zeiten
Mecklenburg-vorpommern
Germany
United-kingdom
Ankara
Turkey
Chicago
Illinois
United-states
Joseph-jasper
Stefan-klotter

Transgene Presents Immunological Data Demonstrating that TG4001, a Novel Therapeutic Cancer Vaccine,

TG4001 can induce de novo immune responses against HPV16 antigens E6 and E7 in patients with advanced HPV16-positive anogenital cancersPatients with complete objective response showed strong vaccine-induced immunoreactivityTransgene is preparing for a potentially registrational studySTRASBOURG, France (BUSINESS WIR.

United-states
Chicago
Illinois
American
Transgene-euronext
Alessandro-riva
Lucie-larguier
Twitter
Linkedin
Corporate-communications
American-society-of-clinical-oncology
Regulatory-news

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.